Check out JPD's new Special Issue, Volume 14, Supplement 2: The Earliest Phase of Parkinson’s Disease: Possibilities For Detection And Intervention.
Aims & Scope
The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It will publish research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and affordable open access.
Editorial Board
The full editorial board of the Journal of Parkinson's Disease can be found on its dedicated website here: Editorial Board.
Author Guidelines
SUBMISSION OF MANUSCRIPT
By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.
From 2023, the Journal of Parkinson’s Disease is an open access journal. All content moving forward will be freely available to the readership. Authors are required to pay an article publishing charge: payment is detailed in the article’s decision letter. Note: Corresponding authors from eligible institutions may be eligible to a waiver or discount on the open access fee; see here for more details.
See the full instructions to authors on the JPD website.
COPYRIGHT
Copyright of your article
Authors submitting a manuscript do so on the understanding that they have read and agreed to the terms of the IOS Press Author Copyright Agreement.
Article sharing
IOS Press adopted Sage’s Article Sharing Policy from 8th of July 2024.
Please go to: Sage’s Author Archiving and Re-Use Guidelines | SAGE Publications Ltd for details. If your manuscript was submitted prior to 8th of July 2024, please contact editorial@iospress.nl with details of your enquiry.
Please visit the IOS Press Authors page for further information.
Abstracted/Indexed in
Biomedical Reference Collection
Cabell's Guide or Directory
Chemical Abstracts Service (CAS)
Embase
MEDLINE
OA@PubMedCentral
PsycINFO
PubMed
PubsHub
SciVerse Scopus
Web of Science: Journal Citation Reports/Science Edition
Web of Science: Science Citation Index Expanded (SciSearch®)
Open Access
Gold open access pricing
The Journal of Parkinson's Disease is an open access journal.
The APC for this journal is US$2800.
Authors may be eligible for discounts to their APC via open access agreements that Sage has with participating institutions. Discounts depend on the terms of the agreement, find out if your institution is participating by visiting the institutional agreements page at IOS Press. Eligibility is determined by the corresponding author’s affiliation at acceptance matching an agreement.
Your article may be eligible for a full or partial waiver due to our participation in initiatives to increase accessibility to publication across the international academic community. More information about discounts and eligibility.
PubMedCentral deposits
This journal deposits all open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library. If an author chooses to publish their paper with open access then the publisher will deposit the article in PMC upon publication.
New Co-Editor-in-Chief Appointed: A new co-Editor-in-Chief (EIC) joined the journal in May 2022. A heartfelt welcome to Lorraine Kalia, and huge thanks to the outgoing EIC Patrik Brundin. Read the news announcements here.
Social Media: The Journal of Parkinson's Disease (JPD) is on Facebook and Twitter, with social media editor Rui Araújo, PhD (University of Porto, Portugal) at the helm. Be sure to follow us and be part of the conversation!
Partnership with WPC: Since April 2020, JPD has partnered with the World Parkinson Coalition (WPC), an organization which fills a unique niche in the global Parkinson's community. The partnership will see our respective teams working together to give a platform to the latest developments in PD research. View the WPC website here.
Clinical Trials Highlights: At the start of 2019, a new journal section co-edited by Kevin McFarthing and Tanya Simuni was launched to raise awareness of the clinical trial landscape in Parkinson’s, promoting discussion and progress in the conduct and outcome of studies; view here.
Parkinson's Webinar Series: JPD works in partnership with The Cure Parkinson’s Trust and Van Andell Institute to produce a series of Quarterly Parkinson's Webinars. Discover more here. The topic of our latest webinar was World Parkinson Congress 2023 Highlights. Watch the webinar recording here.
JPD Open Access Special Issues: Abstracts of the 6th World Parkinson Congress, July 4–7, 2023, Barcelona, Spain - Vol.13, Iss.s2; Linking Immune Activation and Parkinson’s Disease - Vol.12, Iss.s1; Repairing the Parkinsonian Brain – Vol.11, Iss.s2; Digital Technology in PD Care & Research – Vol.11, Iss.s1; Clinical Care of Parkinson's – Vol.10, Iss.s1; Gut-Brain Axis in PD – Vol.9, Iss.s2 poses the question as to whether PD stars in the gut for all patients or a small subgroup; and PD 20 Years from Now – Vol.8, Iss.s1 addresses where Parkinson's research & treatment will be 20 years from now and you can read more in the mailing here.
Sustainable Development Goals
The content of this journal relates to SDG:
Visit the SDG page for more information.
Supporting Diversity and Inclusion
This journal supports IOS Press' actions relating to the Sustainable Development Goals (SDGs) and commits to the Diversity and Inclusion Statement.
More information will be available in due course. Check the SDGs page for updates.
 |
 |
 |
|
|
|
 |
 |
 |
